InvestorsObserver
×
News Home

Evogene Schedules First Quarter 2024 Financial Results Release

Thursday, May 09, 2024 07:00 AM | PR Newswire via QuoteMedia

Mentioned in this article

Evogene Schedules First Quarter 2024 Financial Results Release
Evogene Schedules First Quarter 2024 Financial Results Release

PR Newswire

Zoom conference call scheduled for 9:00 AM ET

REHOVOT, Israel , May 9, 2024 /PRNewswire/ -- Evogene Ltd . (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024 .

Evogene Logo

Later that day, Company management will host a conference call to discuss the results at 9:00 AM Eastern Time ( 4:00 PM Israel time).

To join the conference, please register in advance: https://us06web.zoom.us/webinar/register/WN_GBxR-LTZRYy9D7OIt2YW0g

The entire conference will be available online on the company's website a few days after.

About Evogene:

Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational biology company leveraging big data and artificial intelligence, aiming to revolutionize the development of life-science-based products by utilizing cutting-edge technologies to increase the probability of success while reducing development time and cost.

Evogene established three unique tech-engines - MicroBoost AI , ChemPass AI and GeneRator AI . Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes ( MicroBoost AI ), small molecules ( ChemPass AI ), and genetic elements ( GeneRator AI ).

Evogene uses its tech-engines to develop products through strategic partnerships and collaborations, and its four subsidiaries including:

  1. Biomica Ltd. ( www.biomicamed.com ) - developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI ;
  2. Lavie Bio Ltd. ( www.lavie-bio.com ) - developing and commercially advancing, microbiome-based ag-biologicals powered by MicroBoost AI ;
  3. AgPlenus Ltd. ( www.agplenus.com ) -  developing next-generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI ;
  4. Casterra Ag Ltd. ( www.casterra.co ) - developing and marketing superior castor seed varieties producing high yield and high-grade oil content on an industrial scale for the biofuel and other industries powered by GeneRator AI .

For more information, please visit: www.evogene.com .

Contacts
Rachel Pomerantz Gerber
Head of Investor Relations at Evogene
rachel.pomerantz@evogene.com
Tel: +972-8-9311901

Logo: https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg

Cision View original content: https://www.prnewswire.com/news-releases/evogene-schedules-first-quarter-2024-financial-results-release-302141103.html

SOURCE Evogene

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App